Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer

The anticancer properties of ceramide, a sphingolipid with potent tumor-suppressor properties, can be dampened via glycosylation, notably in multidrug resistance wherein ceramide glycosylation is characteristically elevated. Earlier works using the ceramide analog, C6-ceramide, demonstrated that the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biochem Pharmacol
Autors principals: Morad, Samy A. F., Davis, Traci S., MacDougall, Matthew R., Tan, Su-Fern, Feith, David J., Desai, Dhimant H., Amin, Shantu G., Kester, Mark, Loughran, Thomas P., Cabot, Myles C.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722210/
https://ncbi.nlm.nih.gov/pubmed/28189725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2017.02.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars